| abstract |
The present invention provides a compound of the formula (I), or a pharmaceutically acceptable derivative thereof. These compounds are protein kinase inhibitors, particularly inhibitors of GSK-3 protein kinases in mammals. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods for using those compounds and the compositions in the treatment of various protein kinase-mediated disorders, such as diabetes, cancer, stroke and Alzheimer's disease. |